Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 7,514 Cr.
- Current Price ₹ 272
- High / Low ₹ 321 / 220
- Stock P/E 45.8
- Book Value ₹ 66.6
- Dividend Yield 0.22 %
- ROCE 12.1 %
- ROE 9.36 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company's working capital requirements have reduced from 49.5 days to 28.5 days
Cons
- Company has a low return on equity of 12.7% over last 3 years.
- Dividend payout has been low at 9.39% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.37%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
902 | 1,008 | 1,273 | 1,429 | 1,359 | 1,606 | 2,877 | 2,691 | 2,823 | 2,850 | |
825 | 892 | 1,124 | 1,275 | 1,239 | 1,401 | 2,541 | 2,444 | 2,550 | 2,572 | |
Operating Profit | 76 | 116 | 149 | 154 | 120 | 205 | 337 | 247 | 273 | 278 |
OPM % | 8% | 12% | 12% | 11% | 9% | 13% | 12% | 9% | 10% | 10% |
3 | 2 | 4 | 6 | 33 | 9 | 21 | 29 | 49 | 53 | |
Interest | 18 | 11 | 10 | 16 | 15 | 18 | 17 | 22 | 22 | 16 |
Depreciation | 28 | 27 | 29 | 41 | 48 | 45 | 47 | 70 | 89 | 89 |
Profit before tax | 32 | 81 | 113 | 103 | 90 | 151 | 294 | 183 | 211 | 226 |
Tax % | 23% | 12% | 32% | 24% | 13% | 19% | 18% | 27% | 26% | |
25 | 71 | 77 | 78 | 79 | 123 | 240 | 135 | 156 | 164 | |
EPS in Rs | 24.56 | 70.71 | 76.66 | 15.54 | 17.46 | 4.65 | 9.09 | 5.08 | 5.64 | 5.98 |
Dividend Payout % | 4% | 0% | 0% | 2% | 10% | 11% | 8% | 10% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 21% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 7% |
TTM: | 53% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
1 Year: | 3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 13% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 |
Reserves | 224 | 294 | 370 | 405 | 396 | 992 | 1,230 | 1,367 | 1,781 |
199 | 79 | 194 | 143 | 138 | 75 | 99 | 372 | 139 | |
158 | 227 | 258 | 359 | 445 | 616 | 785 | 537 | 865 | |
Total Liabilities | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,840 |
207 | 195 | 273 | 327 | 327 | 315 | 361 | 694 | 699 | |
CWIP | 33 | 48 | 30 | 31 | 23 | 60 | 177 | 88 | 147 |
Investments | 19 | 23 | 20 | 20 | 21 | 25 | 32 | 287 | 444 |
332 | 344 | 509 | 579 | 653 | 1,335 | 1,597 | 1,259 | 1,551 | |
Total Assets | 590 | 610 | 832 | 958 | 1,024 | 1,735 | 2,166 | 2,329 | 2,840 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
135 | 110 | 61 | 161 | 521 | |||||
-3 | -604 | 44 | -362 | -498 | |||||
-115 | 485 | -87 | 241 | -9 | |||||
Net Cash Flow | 17 | -9 | 17 | 40 | 14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 61 | 78 | 83 | 78 | 85 | 87 | 79 | 73 | 78 |
Inventory Days | 61 | 34 | 51 | 48 | 57 | 59 | 60 | 50 | 47 |
Days Payable | 70 | 85 | 83 | 112 | 154 | 155 | 127 | 93 | 145 |
Cash Conversion Cycle | 52 | 27 | 51 | 13 | -12 | -8 | 12 | 30 | -20 |
Working Capital Days | 52 | 29 | 59 | 36 | 37 | 20 | 54 | 66 | 28 |
ROCE % | 22% | 26% | 20% | 14% | 20% | 25% | 13% | 12% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ('Listing Regulations')
18h - Disclosure regarding the receipt of the Income-tax Assessment Order for Assessment Year 2020-21
- Action Taken Report For Non-Compliance With Regulations 23 (9)Of SEBI (LODR) Regulations, 2015 20h
- Unaudited Financial Results For The Quarter Ended June 30, 2024 21h
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Jul - The Investor & Analyst Meet to discuss performance for the quarter ended June 30, 2024 is scheduled to be held on Monday, July 29, 2024, …
- Board Meeting Intimation for Board Meeting To Be Held On July 26, 2024 18 Jul
Annual reports
Concalls
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
Leadership[1]
Top supplier in India and amongst top 3 players globally (ex. China) in Essentials and among top 5 globally in Specialities.